![Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review](https://assets.cureus.com/uploads/figure/file/342866/5d130dc09f0711eca49cf575607488ad-Figure-6.png)
Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review
![Dynamic dysregulation of IL-6 and genes functional in NETosis, complement and coagulation in severe COVID-19 illness | medRxiv Dynamic dysregulation of IL-6 and genes functional in NETosis, complement and coagulation in severe COVID-19 illness | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2020/10/14/2020.10.13.20211425/F10.large.jpg)
Dynamic dysregulation of IL-6 and genes functional in NETosis, complement and coagulation in severe COVID-19 illness | medRxiv
![Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions - ScienceDirect Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1246782019300369-gr1.jpg)
Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions - ScienceDirect
![Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions - ScienceDirect Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0887796319301348-gr1.jpg)
Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions - ScienceDirect
![JCM | Free Full-Text | Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center | HTML JCM | Free Full-Text | Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center | HTML](https://www.mdpi.com/jcm/jcm-11-00937/article_deploy/html/images/jcm-11-00937-g001.png)
JCM | Free Full-Text | Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center | HTML
![Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review Cureus | Comparing the Safety and Efficacy of L-Glutamine, Voxelotor, and Crizanlizumab for Reducing the Frequency of Vaso-Occlusive Crisis in Sickle Cell Disease: A Systematic Review](https://assets.cureus.com/uploads/figure/file/342879/60b45af09f0811eca508e5ef1a3c5f79-Figure-7.png)